S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
Log in
NASDAQ:CERT

Certara Stock Forecast, Price & News

$37.23
+0.63 (+1.72 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$35.66
Now: $37.23
$37.50
50-Day Range N/A
52-Week Range
$29.70
Now: $37.23
$41.79
Volume554,765 shs
Average Volume552,159 shs
Market Capitalization$5.70 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies and academic institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

MarketRank

Overall MarketRank

1.24 out of 5 stars

Medical Sector

772nd out of 1,926 stocks

Prepackaged Software Industry

119th out of 285 stocks

Analyst Opinion: 2.2Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CERT
CUSIPN/A
CIKN/A
Phone609-716-7900
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$208.51 million

Profitability

Miscellaneous

Market Cap$5.70 billion
Next Earnings DateN/A
OptionableNot Optionable
$37.23
+0.63 (+1.72 %)
(As of 01/21/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CERT News and Ratings via Email

Sign-up to receive the latest news and ratings for CERT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Certara (NASDAQ:CERT) Frequently Asked Questions

Is Certara a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Certara in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Certara stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CERT, but not buy additional shares or sell existing shares.
View analyst ratings for Certara
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Certara?

Wall Street analysts have given Certara a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Certara wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as Certara's CEO?

1,448 employees have rated Certara CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among Certara's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What price target have analysts set for CERT?

5 brokerages have issued 12 month target prices for Certara's stock. Their forecasts range from $33.00 to $41.00. On average, they anticipate Certara's stock price to reach $36.00 in the next year. This suggests that the stock has a possible downside of 3.3%.
View analysts' price targets for Certara
or view Wall Street analyst' top-rated stocks.

Who are some of Certara's key competitors?

Who are Certara's key executives?

Certara's management team includes the following people:
  • Dr. Edmundo Muniz, Chief Exec. Officer and Director
  • Dr. William F. Feehery, CEO & Director (Age 49)
  • Mr. Andrew Schemick, Chief Financial Officer
  • Mr. M. Andrew Schemick, Chief Financial Officer (Age 46)
  • Mr. Gregory B. Smith, Chief Information Officer
  • Prof. Amin Rostami PharmD, Ph.D., FCP, Chief Scientific Officer
  • Mr. Richard M. Traynor, Sr. VP & Gen. Counsel (Age 49)
  • Mr. Mark Hovde, Sr. VP of Strategy and Corp. Devel. (Age 63)
  • Mr. Ryan Carpentier, Sr. VP of Global Sales
  • Ms. Jieun W. Choe, Chief Strategy & Marketing Officer (Age 46)

When did Certara IPO?

(CERT) raised $500 million in an initial public offering (IPO) on Friday, December 11th 2020. The company issued 24,400,000 shares at $19.00-$22.00 per share. Jefferies, Morgan Stanley, BofA Securities, Credit Suisse, Barclays and William Blair acted as the underwriters for the IPO.

What is Certara's stock symbol?

Certara trades on the NASDAQ under the ticker symbol "CERT."

When did Certara's quiet period expire?

Certara's quiet period expired on Wednesday, January 20th. Certara had issued 29,055,000 shares in its IPO on December 11th. The total size of the offering was $668,265,000 based on an initial share price of $23.00. During Certara's quiet period, underwriters and any insiders that worked on the IPO were prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Who are Certara's major shareholders?

Certara's stock is owned by a number of retail and institutional investors. Top institutional investors include Summit Creek Advisors LLC (0.04%).

Which institutional investors are buying Certara stock?

CERT stock was purchased by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC.

How do I buy shares of Certara?

Shares of CERT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Certara's stock price today?

One share of CERT stock can currently be purchased for approximately $37.23.

How big of a company is Certara?

Certara has a market capitalization of $5.70 billion and generates $208.51 million in revenue each year.

What is Certara's official website?

The official website for Certara is www.certara.com.

How can I contact Certara?

Certara's mailing address is 100 OVERLOOK CENTER SUITE 101, PRINCETON NJ, 08540. The company can be reached via phone at 609-716-7900.

This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.